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The alkylating agent cyclophosphamide (CYP) 1 may suppress or enhance both B 
and  T  cell-mediated  immune  responses  in  vivo  but  requires  microsomal  enzyme 
activation for in vitro efficacy. 4-hydroperoxycyclophosphamide (4-HC) is a synthetic 
compound  spontaneously  hydrolyzed  in  aqueous  solution  to  4-hydroxycyclophos- 
phamide, the initial  metabolite formed by microsomal activation, and which subse- 
quently yields the several active metabolites formed in vivo. It has been demonstrated 
that  CYP  activated  by liver  microsomes  in  vitro  as  well  as  4-HC  will  mimic  the 
immunosuppressive or immunoaugmenting effects observed in  the  intact  organism 
(1-4). 
By  using  4-HC  as  a  probe  of  immunoregulatory  T  subset  function  in  vitro, 
Diamantstein et al.  (4)  recently demonstrated in a  murine system that the enhance- 
ment of the cellular  immune response to sheep  erythrocytes by the compound is  a 
result  of  selective  inactivation  of  suppressor  T  cells  or  their  precursors  at  low 
concentrations (3). These data provide support for the hypothesis that the enhance- 
ment of cellular  responses  by CYP administered  before antigenic challenge in  vivo 
(5-9) is a result of selective elimination of precursors of suppressor T  cells.  Diamant- 
stein  et  al.  (2, 4)  have further demonstrated that  the murine inducer T  cell subset 
mediating humoral immunity is relatively more sensitive to lower concentrations of 
4-HC than are differentiated  suppressor T  cells  for humoral responses or effector T 
cells mediating delayed-type hypersensitivity. 
This selective property of differential concentrations of 4-HC has been employed in 
the  studies  described  here  to  investigate  functional  immunoregulatory  subsets  of 
human T  cells  involved in a  pokeweed mitogen (PWM)-driven polyclonal immuno- 
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globulin (Ig) secretion assay. In this report, data are presented that demonstrate that 
low concentrations of 4-HC selectively inhibit the differentiation of presuppressors to 
suppressor-effector  cells.  T  cell  inducers  were  found  to  be  sensitive  to  moderate 
concentrations, whereas suppressor effector function is resistant to all but the highest 
in vitro levels of 4-HC. The 4-HC-sensitive presuppressor is further shown to be of the 
OKT4+,OKT8 -  phenotype. The effects of 4-HC on suppressor precursors occur not 
only  at  concentrations  that  are  cytotoxic,  but  also  at  levels that  do  not  result  in 
measurable DNA cross-linking or decreased blastogenesis. In addition, T  cell-regulated 
B cell differentiation is reversibly blocked by treating B cells with low concentrations 
of 4-HC but may be restored if treated B cells are cocuhured with T  cells depleted of 
mitogen-inducible suppressor activity, suggesting that B  cell subpopulations are also 
differentially susceptible to CYP. 
Materials  and  Methods 
Isolation of  Lymphocyte Populations.  Peripheral leukocyte populations were obtained from huffy 
coats separated by gravity sedimentation of 500  ml of citrated blood from volunteer donors. 
Phagocytic mononuclear cells were  depleted by diluting each  buffy coat  1:2  with  medium 
containing carbonyl iron (1 mg/ml) in 50-ml aliquots and incubating the mixture for 60 rain 
with gentle continuous agitation. Each leukocyte population was then layered in 10-ml aliquots 
on 3-ml Ficoll-Hypaque density gradients in  15-ml siliconized glass tubes and centrifuged 40 
min at 400 g. The interface layer was resuspended in RPMI 1640 (Grand Island Biological Co., 
Grand Island, N. Y.) and washed twice. The viability of the purified lymphocyte populations 
was routinely >99%  and  monocyte contamination  was  always <2%  by nonspecific esterase 
staining and latex-bead ingestion. 
E-rosette-positive (E  +) and -negative (E-) lymphocyte populations were obtained by rosetting 
with  sheep  erythrocytes  (SRBC)  that  had  been  treated  with  2-aminoethylisothiouronium 
bromide  (AET)  according  to  the  method  of Kaplan  and  Clark  (10).  AET-treated  sheep 
erythrocytes were washed  twice in  RPMI  1640  containing  10%  fetal calf serum  (FCS) and 
antibiotics and mixed with lymphocyte suspensions at a ratio of 50 SRBC: 1 lymphocyte in 15- 
ml conical, siliconized glass tubes. These mixtures were centrifuged for 8  min  at  200  g  and 
incubated  18 h at 4°C. The pellets were gently resuspended, rosette-forming cells (RFC) were 
enumerated, and the E ÷ population sedimented on Ficoll-Hypaque at 400 g for 40 min. Sheep 
erythrocytes were removed by brief hypotonic lysis and the pellets resuspended in 3% saline to 
isotonicity. E + and  E- populations (for brevity, the E- population, which always contained 
>70% surface Ig  ÷ [sIg  +] B cells and ~10-15% null cells, is subsequently referred to as B cells) 
were washed twice in supplemented RPMI  1640 and kept at 4°C.  Purity of these and other 
populations was determined by enumerating sIg  + cells with rabbit anti-human F(ab')2-coupled 
bovine  erythrocytes  (Grand  Island  Biological Co.)  according  to  the  method  of Gold  and 
Fudenberg (11) as previously described (12). 
Isolation of T Cell Subsets by Complement-mediated  Lysis with  the Monoclonal Antibodies OKT4 and 
OKT8.  The  monoclonal antibodies OKT3,  OKT4,  and  OKT8  used  in  these studies were 
generously donated by Dr. Gideon Goldstein of Ortho Pharmaceutical Corp., Raritan, N. J. 
OKT4  monoclonal antibody reacts with a  subset  that  comprises 60%  of peripheral T  cells, 
proliferates in response to soluble antigen, and contains the inducer T subpopulation for PWM- 
driven, immunoglobulin-secretion assays (13).  A second monoclonal antibody, OKT8, reacts 
with 30-35% of peripheral T  cells and is described as defining the cytotoxic/suppressor subset 
in functional assays (14). The unfractionated T  cell populations were resuspended at 50 ×  l0  s 
cells/ml in RPMI  1640 containing 5% FCS. 0.2 ml of the appropriate monoclonal antibody at 
a  dilution of  1:50  was  added  to  0.2  ml  of the  T  cell suspension,  and  the  cells were  then 
incubated for 45 min at room temperature. After incubation, rabbit complement (C) was added 
at a final dilution of 1  : 10 and incubation was continued for 1 h at 37°C in a humid atmosphere. 
This entire procedure was repeated twice to thoroughly deplete the antibody-binding cells of 
the designated T  cell subset. FACS-II (B-D FACS Systems, Mountain View, Calif.) analysis of 
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OKT3 +  cells,  >90%  OKT8 +  cells,  and  <4%  OKT4 +  cells.  The  OKT8-treated  population 
contained  >90%  OKT3 + cells, >90%  OKT4  + cells, and  <4%  OKT8 + cells.  Because of these 
results, the notation OKT4 + is used to designate the T  subset  remaining after treatment  with 
OKT8 plus C and OKT8 + is used for the reciprocal population remaining after treatment with 
OKT4 plus C. 
4-HC.  4-HC  was  synthesized  in  the  laboratory  of  Michael  Colvin  at  Johns  Hopkins 
Oncology Center, Baltimore, Md. 4-HC is a relatively unstable compound which spontaneously 
hydrolyzes in aqueous solution to 4-hydroxycyclophosphamide, the compound formed by liver 
microsomal activation of cyclophosphamide. 4-HC and 4-hydroxycyclophosphamide have been 
previously shown to have similar cytotoxic activity and cause comparable cross-linking of DNA 
at  equimolar  concentrations  (M.  Colvin,  unpublished  data).  4-HC  was  maintained  as  a 
dessicated powder at -70°C  and prepared in a stock solution of RPMI  1640 medium with 5% 
FCS within 30 s of lymphocyte exposure. Cell suspensions were added  immediately to obtain 
the appropriate  final dilution of 4-HC and  further incubated  1 h  at 37°C in a  humidified 5% 
CO2  atmosphere.  After  4-HC  exposure,  the  cell  suspensions  were  washed  three  times  and 
prepared in appropriate dilutions for functional assays. No immediate cytotoxic effects of 4-HC 
were noted after drug exposure over the entire range of concentrations from  10 -4 to I00 nmol/ 
ml with viability of all treated and washed cell populations being uniformly >99% by trypan 
blue dye exclusion. 
Coculture Methods.  IgG produced  by isolated subpopulations  and  in coculture experiments 
was quantitated  by a  radioimmunoassay  technique as previously described  (15).  Lymphocyte 
populations  were  adjusted  to  a  final  concentration  of  2  ×  106  cells/ml  in  RPMI  1640 
supplemented with glutamine, 0.1 ng/ml gentamicin, and previously screened, heat-inactivated 
10%  FCS.  The  cell  suspensions  were  incubated  in  flat-bottomed  microtiter  plates  (Linbro 
Chemical  Co.,  Hamden,  Conn.)  for  7  d  at  37°C  in  a  humidified  5%  CO2  atmosphere.  In 
coculture experiments, ratios of B/T cells were maintained  at  1:2,  and T  cell subpopulations 
and putative suppressor populations were recornbined in equal T/T cell ratios unless otherwise 
noted.  The  total  well volume was  350 p.1. In some experiments, T  cells were irradiated  with 
2,000 rad x-irradiation from a General Electric Maxitron 250 x-ray machine using 0.25-mm Cu 
and  l-ram AI filters.  Proliferative responses  were determined  on day  3 of culture  after a  6-h 
pulse with 2 ~Ci/well of tritiated  thymidine  ([3H]Tdr)  (sp act  6.7  Ci/mmol) and subsequent 
harvesting of the entire contents of the welt for liquid scintillation counting. Affinity-column- 
purified  human  IgG  or  IgM,  previously  shown  to  be  specific  by  gel  double  diffusion  and 
immunoelectrophoresis,  was  labeled  with  1 mCi  of 125I using  a  chloramine  T  method.  The 
dilution of anti-IgG or IgM that  bound 60% of a  suitable amount of labeled immunoglobulin 
was determined. Anti-IgG and anti-IgM were prepared by multiple rabbit immunizations with 
purified  protein  followed by  affinity-column  purification  of the antibody.  Antigen-antibody 
dilution curves were constructed for an antigen range of 1-30 ng and down to a  1:8,000 dilution 
of antiserum.  The amount of goat anti-rabbit  Ig added  to precipitate the rabbit  Ig was twice 
the equivalence amount. From  10 to 100 p.l of culture supernatant  or standard  was added to 20 
/xl of anti-IgG for  1 h  at  37°C  in  10-  x  75-mm  plastic  Falcon  tubes  (Falcon  Labware,  Div. 
Becton, Dickinson & Co., Oxnard, Calif.) after which 10/zl of goat antirabbit Ig was added and 
the mixture incubated  for  1 h  at  37°C.  After overnight incubation  at 4°C,  1.0 ml of 0.01  M 
Tris, pH  7.0-7.4, was added  to each tube.  The tubes were centrifuged at 4°C and  2,000 g for 
20  min after which  the supernatants  were discarded  and  the pellet counted.  Standards  were 
prepared  in 0.01  M  Tris with  1% bovine serum albumin.  The binding of labeled Ig could be 
>90% specifically inhibited by cold Ig. 
Concanavalin A  (Con A)-Induced Suppression of Ig Secretion.  T  lymphocyte populations or T  cell 
subsets  from normal  donors were activated  in the presence of 25 #g/ml Con A  (Calbiochem- 
Behring Corp., San Diego, Calif.)  for 48 h  in  RPMI  1640 supplemented with  10%  FCS, 200 
mM L-glutamine, antibiotics, and 25 mM Hepes buffer at a concentration of 4 X  106 cells/ml. 
Untreated control cells were cultured in an identical fashion without Con A. After activation, 
cultured T  cells were washed three times, adjusted  to a concentration of 2 ×  106 cells/ml, and 
incubated  in  standard  culture  media  for  20  rain  in  the  presence  of 40 ~g/ml  mitomycin C 
(Bristol Laboratories,  Syracuse, N. Y.). These activated T  cells and subsets were subsequently 
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cocuhures to determine Con A-induced suppression of Ig secretion. In preliminary experiments, 
0.3 M  a-methyl-n-mannoside (Sigma Chemical Co., St. Louis, Mo.) was included in the wash, 
but was found not to influence the results significantly and reported experiments were performed 
in  the absence  of a-methyl-D-mannoside.  The  percent  suppression  of total  Ig secretion  was 
calculated according to the following formula: 
(Ig secretion by B +  T  +  cultured T  cells) 
Percent suppression  =  -  (Ig secretion by B +  T  +  Con A-cultured T  cells) X  i00, 
Ig secretion by B +  T  +  cultured T  cells 
where  B  +  T  cell cocultures were  performed  using  normal  autologous  cell  populations  and 
allogeneic cultured  T  cell controls.  Total  cocuhured  cell numbers  in  the  Con  A  suppressor 
assays consisted of 2 X  l0  b cells of each T  cell population. 
Results 
Inhibition  of T  Cell Blastogenic Responses by 4-HC.  To obtain a  dose-response curve 
for cytotoxicity of 4-HC on T  cells,  the effects of a  1 h  in  vitro incubation of the 
compound with purified normal T  cells (>96% E RFC +) were determined by trypan 
blue dye exclusion as well as functional impairment of DNA synthesis by blastogenesis 
in response to phytohemagglutinin (PHA), Con A, and PWM. 4-HC was diluted in 
standard culture media and isolated T  cells were exposed to final concentrations of 
between  1074 and  100 nmol/ml for  1 h.  In no instance was immediate cytotoxicity 
demonstrable by trypan blue dye exclusion after the 1-h incubation and three washes. 
Drug-induced cytotoxicity as a result of DNA cross-linking was, however, evident at 
72 h  by decreased [3H]TdR incorporation in response to mitogenic stimulation.  As 
shown  in  Fig.  1, purified T  cells demonstrated  decreased blastogenesis  to all  three 
mitogens after exposure to a concentration of-30 nmol/ml 4-HC with complete loss 
of DNA synthetic capacity at drug levels >80 nmol/ml. The drug concentration that 
results in initial DNA cross-linking in lymphoid cell populations after in vitro exposure 
to 4-HC  has been previously shown  to  be ~>20 nmol/ml  (M.  Colvin, unpublished 
data).  It  should  be noted that  there  is neither an  immediate nor a  72-h cytotoxic 
effect of 4-HC concentrations <1  nmol/ml, although significant effects on mitogen- 
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Fl~.  1.  Dose-response  curve of mitogen responsiveness  of 4-HC-pretreated T  cells. T  cells were 
incubated for 1 h with the indicated concentration of 4-HC, washed,  cultured 72 h in the presence 
of mitogen, and [3H]TdR incorporation after a 6-h pulse was determined. (- - -) Con A, 25 #g/ml 
(control counts per minute above background [A cpm}:  18,859 +  3,189 SEM); (--) HA-17, 0.5 pg/ 
mt (control  A cpm: 31,921 -I- 1,817 SEM); and  (---) PWM,  1:200 (control  A epm: 38,693 _+. 5,853 
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induced T  suppressor activity were demonstrable at these very low levels as described 
below. Treated cell populations were also examined for viability after incubation by 
trypan blue dye exclusion  when  the cells were  harvested  for functional  assays. No 
significant effects of 4-HC on T  or B cell recovery or viability were apparent when 
cells were exposed to concentrations of <10 nmol/ml and subsequently cultured  for 
up to  7 d, although cell yields were reduced by as much as 70%  after treatment  at 
concentrations  >40  nmol/ml.  The  concentration  of 20  nmol/ml  was  empirically 
selected for its maximum effects on Con A-induced suppression without resulting in 
a >10% decrement in cell yields after 48 h. 
Augmentation  of Ig  Secretion  by  Pretreatment  of T  Cells  with  4-HC.  To  compare  the 
relative sensitivity of suppressor and inducer T  cells in the Ig secretion assay, T  cells 
were pretreated  with  graded  concentration  of 4-HC,  washed,  and  then  cocuhured 
with  autologous  B  cells  for  7  d.  The  data  obtained  for  three  to  four  separate 
experiments  are  shown  in  Table  I.  The  in  vitro  production  of IgG and  IgM  by 
cocuhured  B  and 4-HC-pretreated T  cells in  the  absence of monocytes  (<2%)  was 
compared with baseline secretion by untreated populations and with production after 
2,000-rad  x-irradiation  of T  cells.  Ig  secretion  after  the  7-d  incubation  period  is 
expressed as ng Ig/ml, which is equivalent in this culture system to ng/3 X  105 total 
lymphocytes or ng/l X  105 cultured B cells.  As previously described (16), 2,000-rad x- 
irradiation of cocuhured T  cells at a  2:1  T/B cell ratio results in an -50% increment 
in  Ig  secretion,  although  this  augmentation  is  not  seen  at  lower  T/B  cell  ratios, 
probably because inducer function is also partially radiosensitive (17). 4-HC pretreat- 
ment was found to have a parallel effect on Ig secretion, although at lower concentra- 
tions (<10 nmol/ml), the augmentation obtained was approximately 30%, whereas at 
a concentration of 20 nmol/ml, Ig secretion was increased by nearly 50% for both IgG 
and IgM. Treatment of T  cells with concentrations of 60 or 100 nmol/ml resulted in 
a  sharp decline  in  Ig secretion to levels obtained with  isolated  B  cells alone.  These 
TABLE  I 
Effect of 4-HC Pretreatment of T Cells on Subsequent IgG and IgM Secretion 
by Autologous B Cells in Coculture 
Composition of cocuhure  IgG secretion  IgM secretion 
ng/ml per 7 d 
B +  T  +  PWM control  1,397 ±  162  2,009 -+ 332 
B  +  pretreated T  +  PWM  Percent of control  Percent of control 
B +  Tx*  152.3 _.  10.5  153.4 ±  6.9 
B +  T~o-,~:  107.3 +  9.9  104.4 -t- 7.4 
B +  T~0 ~  118.8 ±. 3.2  114.6 -4- 6.3 
B  +  Tw-~  135.1  ±  3.8  127.8 +_  1.9 
B  +  T10  ~  130.8 +  7.4  121.2 ±  9,7 
B  +  T1  133.3 ±  7.9  123.6 ±  1,8 
B  +  Te0  143.4 ±  5.1  148.5 +  5.3 
B  +  T60  42.8 +- 5.3  41.1  ±  1.5 
B  +  T~00  11.5 +. 4.3  5.9 +_ 3.2 
* x,  2,000-rad  x-irradiation.  Data  presented  as  the  mean  of  three 
experiments +  SEM. 
:~ Subscripts represent 4-HC concentrations in nmol/ml. 
DNA cross-linking occurs at concentrations ~20 nmol/ml. 
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data therefore suggest an initial selective effect of  4-HC on mitogen-induced suppressor 
T  cell function at  very low concentrations followed by concomitant elimination of 
inducer activity at  levels that yield maximum DNA cross-linking (30-60 nmol/ml) 
and thus abrogation of both T  cell functions. The possibility of carry-over of 4-HC or 
its metabolites with subsequent leakage during incubation at higher concentrations 
was excluded by coculturing T  cells treated with  100 nmol/ml 4-HC with untreated 
T  and B cells, which resulted in no decrease in Ig synthesis. 
Effect of 4-HC on Con A-inducible  T  Cell Suppression.  To determine the effects of 4- 
HC  on  Con  A-inducible suppressor  function, T  cells were  incubated  48  h  in  the 
presence of 25 #g/ml of Con A after exposure to graded concentrations of 4-HC and 
assayed for suppression of IgG and IgM secretion by untreated allogeneic B cells. The 
baseline Ig secretion selected as the 100% control level for these four experiments was 
obtained by coculturing allogeneic T  cells that had been preincubated in standard 
media alone and were mitomycin C-treated after harvesting. As shown in Table II, T 
cells incubated in the presence of 25 #g/ml Con A suppressed IgG secretion by ~85% 
and IgM secretion by 90%.  Pre-exposure of the Con A-cultured T  cells to concentra- 
tions of 4-HC ranging from  10  -2 nmol/ml to 20 nmol/ml resulted in cell yields after 
48 h that were within :tz 10% of control cultures and were >90% viable by trypan blue 
dye exclusion. These drug-exposed, Con A-activated T cells were, however, completely 
devoid of suppressor activity for either IgG or IgM synthesis, even when exposed to 
lower 4-HC concentrations, and despite normal blastogenic responses to Con A after 
exposure (Fig.  1).  In several experiments, there was  marked  augmentation of both 
IgG and IgM synthesis when 4-HC and Con A-treated T  cells were added to B +  T 
cell cocultures, suggesting that the treated cell populations were enriched for inducer 
activity that further augmented baseline Ig secretion by providing a  more favorable 
inducer T:B cell effector ratio. 
Because allogeneic T  cells did not  demonstrate suppressor function in  this assay 
TABLE II 
Effect of 4-HC on Con-A-inducible T Cell Suppression of Ig Synthesis 
T  suppressor cells added to B +  T  IgG secretion  IgM secretion 
+  PWM coculture 
T  cells cultured 48 h with media alone  1,750 ±  462 ng/ml per 7 d  2,450  ±  599 ng/ml per 7 d 
(100%)  (100%) 
T  cells incubated 48 h with 
25 ~g/ml Con A 
15.5 ±  1.3%*  10.8 +  3.3%* 
T  cells treated with 4-HC 
before Con A activation 
10  -~ nmol/ml  100.6 +  6.4*  134.1 +  7.8 
10  -2 nmol/ml  107.4:1:7.6  117.6 -4- 4.9 
1 nmol/ml  105.9:1:4.6  140.9 +  14.1 
10 nmol/ml  135.8 ±  4.6  99.2 ±  6.7 
20 nmol/ml  170.0 ±  14.5  185.7 +  4.9 
Data  expressed as  means of four experiments  +  SEM.  T  cells  were  pretreated  with  the  designated 
concentrations of 4-HC for 1 h at 37°12, washed three times, and incubated 48 h  in the presence of 25 
/tg/ml Con A. 
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unless activated by mitogens, the 4-HC metabolite was also used to determine whether 
CYP  exerts  its anti-suppressor activity before  the  induction of suppression, on  the 
mitogen-induced  suppressor-effector cell, or both. Table III presents data obtained in 
three experiments in which T  cells were activated in the presence of 25/~g/ml Con A 
and examined for suppression of IgG or IgM synthesis using allogeneic T  +  B  cell 
cocuhures. Suppressor activity was completely abrogated by pretreatment of T  cells 
with  10 nmol/ml 4-HC before Con A activation. If Con A-activated cells were drug- 
treated  either  at  10  or  80  nmol/ml after  the  48-h  Con  A  incubation and  before 
mitomycin C  treatment, absolutely no reduction in suppressor activity was observed. 
To eliminate the possibility that synergism or competition between mitomycin C  and 
4-HC  might  result  in inactivation of potential suppressors in the  4-HC  pretreated 
group,  similar experiments were  performed  excluding the  mitomycin C  treatment. 
Again, drug-induced loss of T  suppression was  virtually  100%.  In aggregate,  then, 
these  data  provide evidence that  4-HC  is  capable of blocking mitogen-induced T 
suppression  at  concentrations well  below  those  required  to  block  DNA-synthetic 
activity. The abrogation of suppression appears to occur by preventing the maturation 
of presuppressors to suppressor-effectors either directly, or by blockade of suppressor- 
inducer subset function. Further, mature suppressor-effector function is resistant to 
concentrations of 4-HC (80 nmol/ml) that fully block inducer T  cell function (Table 
I) in this assay. 
Sensitivity of B  Cell Function  to 4-HC. The immunosuppression  caused by in vivo CYP 
administration in animals was  originally observed as  a  decrease  in serum  Ig levels 
with  a  concomitant loss  of primary follicles in spleen and  lymph nodes  (18).  The 
effects of CYP on the immune system were, therefore, attributed to selective cytotoxic 
activity against B cells, whereas its effects on delayed hypersensitivity were discovered 
at  a  later date.  Because the in vitro Ig secretion assay provides the opportunity to 
examine both T  and B cell sensitivity to 4-HC, Ig secretion after exposure of the B 
cell population to 4-HC was also examined. As shown in Table IV for a  total of four 
TABLE  III 
Effect of 4-HC on Con A-induced T Suppressor Function Before and After Mitogen Activation 
Percent  Percent 
Suppressor population added to B + T cocuhures  IgG secretion  suppres- IgM secretion  suppres- 
sion  sion 
None 
T ceils activated 48 h with 25/.tg/ml Con A 
T  cells pretreated with 10 nmol/ml 4-HC before 
Con A activation 
T cells treated with 4-HC after Con A activation* 
10 nmol/ml 
80 nmol/ml 
ng/mlper 7 d  ng/mlper 7 d 
1,823 ± 708  --  2,235 ± 569  -- 
756 ±  195  59  270 ± 68  88% 
1,810 ± 423  1  3,115 ± 738  0~ 
436 ±  163  76  340 ----. 181  85'7f 
347 +  148  81  553 + 202  75% 
Data presented as the mean of three experiments + SEM. 
* Data obtained with T populations incubated with both 4-HC and mitomycin C after Con A activation. 
Identical results were obtained in similar experiments omitting mitomycin C treatment  to exclude a 
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TABLE  IV 
Effect of 4-HC Pretreatment of B Cells on Subsequent Secretion of IgG and IgM in Culture 
Percent of  Percent of  Composition of coculture  IgG secretion  IgM secretion  control  control 
ng/ml per 7 d  ng/ml per 7 d 
B + T control  1,342:1:332  100%  2,194 ~ 305  100 
B + Tx*  2,418 ± 311  167.8%  3,088 ±  713  140.7 
B + T20  2,422 + 510  168.0%  3,184 ± 582  145.1 
B20 + T  512 ±  147  35.5%  204 ± 80  9.3 
B20 + xT  2,330:1:516  161.6%  2,428 ± 296  110.7 
B~0 + T20  2,068 ± 421  143.4%  3,006 ± 415  137.0 
*  x, 2,000-rad x-irradiation. Means of four to six experiments +- SEM. 
:]: Subscripts represent 4-HC concentrations in nmol/ml. 
to six experiments,  treatment  of B  cells  with  20  nmol/ml  4-HC  results  in  a  nearly 
complete loss of polyclonal Ig secretion on day 7. An unexpected result was obtained, 
however, when the same population of drug-treated B cells from each experiment was 
recombined  with  either  an  irradiated  (2,000  rad)  or  drug-treated  (20  nmol/ml) 
autologous T  cell population. In either case, Ig secretion was restored to normal levels 
with some augmentation  in  total  Ig secretion  above baseline  T  +  B  cell cocultures. 
Thus,  these  data  demonstrate  that  the  augmentation  of B  cell  effector  function 
obtained with low concentrations of 4-HC is not simply a  result  of the effects of the 
drug on suppressor T  cell  function  alone,  but  may result  from an  alteration  in  the 
normal balance between regulatory and effector cell function in both the T  and B cell 
populations.  They further suggest that  treated  B cells are injured  or modified by 4- 
HC  pretreatment  in  some  manner  that  results  in  an  increased  sensitivity  to  T 
suppressor function. Whether this represents a selective kill of a  B cell subpopulation, 
thus effectively altering the suppressor/effector ratios  in coculture, or is the result  of 
increased sensitivity of the response of an individual  B cell to suppression remains to 
be determined. 
Sensitivity  of lsolated T Subset Function to 4-HC.  Because T  suppressor function in the 
polyclonal Ig secretion assay was clearly sensitive to pretreatment  with extremely low 
concentrations of 4-HC, and because the data suggested that the mechanism of action 
of CYP at  these concentrations  is to prevent  the differentiation  of presuppressors  to 
suppressor-effector cells,  further  experiments  were designed  to define  the phenotype 
of the  4-HC-sensitive  suppressor-precursor  cell  using  the  OKT4  and  OKT8  mono- 
clonal antibodies.  To investigate the effects of 4-HC on T  cell subsets defined by the 
monocional antibodies OKT4 and OKT8, complement-mediated lysis of total T  cells 
with  a  1:50  dilution  of each  antibody  was  employed  to  enrich  for  the  reciprocal 
subset. After a double lysis and washing, each cell population was labeled with OKT3, 
OKT4,  and  OKT8,  indirectly  labeled  with  fluoresceinated  goat anti-mouse  Ig, and 
analyzed on the FACS-II. Lysis of the specific subset  in each experiment  was found 
to be >98% complete with >90% of the total residual T  population staining positive 
for the reciprocal  antibody.  Fig.  2  illustrates  the capacity of the total T  population 
and  each of the enriched subsets  to collaborate  with  B  cells  in  the secretion  of IgG 
and  IgM.  As  described  above,  either  2,000-rad  x-irradiation  or  low-dose  4-HC 
pretreatment  of total T  cells resulted in a 40-50% augmentation in Ig secretion when 
pretreated T  cells were cultured with autologous B cells. The OKT4 + subset was also 284  EFFECTS  OF  CYCLOPHOSPHAMIDE  ON  T  SUBSET  FUNCTION 
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Fro.  2.  Ability of T  cells and OKT subsets to collaborate with autologous B cells after 2,000-rad 
x-irradiation or  20  nmol/ml 4-HC  pretreatment.  Data  are  presented as  percent  of control  B  + 
untreated T  cocuhures in the presence of PWM for two representative experiments. Mean control 
IgG secretion  in  these experiments was  1,293  ±  123  ng/ml and  for  IgM,  1,981  :t:  209  ng/ml. 
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Fro.  3.  Ability of 4-HC pretreatment to block Con A-induced suppressor function of T  cells and 
OKT  subsets. T  cells or subsets were activated with  25  #g/ml Con  A  with  and  without 4-HC 
pretreatment and assayed for suppressor activity on allogeneic T  +  B cocuhures. Data are presented 
as percent of control B +  T  eocuhures in the presence of PWM for two representative experiments. 
Mean baseline IgG secretion in these experiments was 1,304 +  178 ng/ml and for IgM, 2,108 +  243 
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fully able to induce Ig secretion, whereas the OKT8  + subset failed to help autologous 
B cells secrete Ig. After x-ray or drug treatment, OKT4  + cells responded as do total 
T  populations  with,  in  these  two  experiments,  a  several-fold augmentation  in  Ig 
secretion by cocuhured B cells.  Only a  weak or nonexistent augmentation could be 
elicited by drug or x-ray treatment of the OKT8  + subset. These results suggested that 
the OKT4  + subset contains both an inducer and a presuppressor population, whereas 
OKT8  ÷ cells represent a differentiated suppressor population because they have been 
previously shown  to  actively suppress  ongoing T-B  collaboration  but  require  the 
presence  of inducer  cells  for  suppressor-effector function  (17).  Both  subsets  were 
therefore examined for their ability to suppress Ig secretion after activation with Con 
A  and  after preexposure to 4-HC.  As shown  in  Fig.  3, OKT4  + cells, although  not 
initially suppressive of Ig secretion (17), are fully capable of  generating Con A-induced 
suppressor activity, which  is  equivalent  in  magnitude  to  that  of unfractionated T 
cells. Pretreatment with 4-HC at the concentration of 20 nmol/ml completely prevents 
the generation of suppressor effectors within the OKT4  + subset and frequently results 
in an augmentation of inducer activity when drug-treated, Con A-activated T  cells 
are added to B +  T  cell cocultures. In contrast, the OKT8  + subset retains suppressor 
activity after Con A activation, which is unaffected by preexposure of this subset to 
4-HC or, apparently, by mitogen activation. These results provide strong support for 
the hypothesis initially proposed by Thomas et al.  (17,  19) that the presuppressor is 
contained within the OKT4  ÷ subset. 
Discussion 
It is well established that  CYP,  in addition to its immunosuppressive properties, 
enhances humoral  as well as cellular immune responses to a  variety of antigens  in 
vivo (1-9). Although CYP-induced potentiation of cellular responses was originally 
ascribed to the elimination of B cells (20), Askenase et al. (7) demonstrated that doses 
of CYP too low to affect antibody production were nonetheless immunoaugmenting 
for delayed-type hypersensitivity. These authors therefore postulated that the enhance- 
ment of delayed-type hypersensitivity in vivo was a result of the selective elimination 
of precursors  of suppressor  T  cells.  Subsequent  in  vivo  experiments  led  to  the 
hypothesis that various immunoregulatory T  cell subsets as well as effectors of both 
cellular and humoral immunity differed in their susceptibility to a given dose of CYP 
(1, 8, 9, 21, 22). 
Although  the  immunoregulatory properties of CYP  cannot  be  demonstrated  in 
vitro, the recent availability of the synthetic compound 4-HC,  which  yields active 
metabolites in aqueous solution, has led to elucidation of these differing susceptibilities 
by murine regulatory and effector lymphocytes. In the experiments described here, 4- 
HC was used in conjunction with monoclonal antibodies to functional T  cell subsets 
to  further characterize regulatory T-B cell  interactions in  a  human,  PWM-driven 
polyclonat Ig secretion assay. The data presented clearly support the contention that 
4-HC in vitro, like CYP administered in vivo, can be either immunosuppressive or 
immunoaugmenting for B cell differentiation and  Ig secretion depending upon the 
concentration and the drug-treated ceil population employed in a given assay. Several 
specific conclusions are also warranted from the results obtained in these studies:  (a) 
T  cell-helper function at high T:B cell ratios is resistant to low-dose 4-HC, although 
both [3H]Tdr incorporation and helper activity decay rapidly when the pretreatment 286  EFFECTS OF CYCLOPHOSPHAMIDE  ON T  SUBSET FUNCTION 
concentration of 4-HC exceeds 40 nmol/ml;  (b)  mitogen-induced T  suppressor func- 
tion,  as  measured  either  by augmentation  in  B  effector function when  T  cells  are 
pretreated or by Con A-induced suppressor activity is exquisitely sensitive to pretreat- 
ment  concentrations  of 4-HC  that  have  no  effect  on  helper  or  mature  suppressor 
function; (c) treatment of B cells at concentrations of 20 nmol/ml blocks Ig secretion 
but this blockade can be overcome if treated B cells  are cocultured in the absence of 
functional  suppressor  T  cells;  (d)  differentiated  T  suppressor  function,  whether 
mediated  by  the  OKT4-,OKT8  +  subset  or  the  mitogen-induced  OKT4+,OKT8  - 
subset  is resistant  to concentrations of 4-HC in excess  of those that  abrogate helper 
activity or prevent differentiation or presuppressors;  and  (e)  4-HC appears to block 
mitogen-induced  suppressor  function  by  preventing  the  differentiation  of mature 
suppressor-effector cells  from OKT4+,OKT8  -  precursors. 
The cytotoxic effects of 4-HC on total T  lymphocyte populations are undetectable 
until  concentrations of ~30-40 nmol/ml are obtained,  after which there is  a  sharp 
decline in [aH]TdR incorporation in response to the mitogens PHA, Con A, or PWM. 
Despite this apparent lack ofT cell sensitivity at lower 4-HC concentrations, however, 
augmentation in secreted Ig levels was consistently observed even after pretreatment 
of T  cells  with  as  little  as  l0  -3  nmol/ml.  The augmentation  observed  after  4-HC 
pretreatment  suggested  the  existence  of a  presuppressor  subset  within  the  total  T 
population which differentiated in the presence of PWM and the maturation of which 
was blocked by pretreatment  with 4-HC. This hypothesis was confirmed in the Con 
A-induced T-suppressor assay. Pretreatment of T  cells  before Con A activation with 
very low concentrations of 4-HC completely blocks the ability of activated T  cells  to 
suppress allogeneic B +  T cell cocultures. That low-dose CYP exerts its antisuppressor 
effect at the level  of the presuppressor was demonstrated by the inability of 4-HC to 
affect T  suppressor function when used to treat T  cells after a 48-h Con A activation, 
even at a  concentration of 80 nmol/ml. Thus, low-dose 4-HC prevents the differen- 
tiation of suppressor-effector cells  for B cell  differentiation. 
In experiments designed to determine the phenotype of the CYP-sensitive T  subset, 
OKT8  +- and OKT4+-enriched subsets were compared for their ability to suppress B 
+  T  cell  cocuhures  after  Con  A  activation  as  well  as  their  ability  to  support  Ig 
synthesis when recombined with autologous B cells. As has been previously described 
(13,  17, 23, 24) the OKT8  ÷ subset fails  to support Ig synthesis when cocultured with 
B  cells  alone.  Pretreatment  of OKT8  + cells  with  4-HC  or  2,000  tad  x-irradiation 
before cocuhure with B cells also failed to augment the minimal Ig synthesis obtained 
with untreated OKT8  + cells, confirming the absence of any cells with inducer function 
within this subset (13,  17). Because the OKT4  + subset has been demonstrated to yield 
a  T  suppressor  population  when  activated  with  PWM  (19),  each  subset  was  also 
examined  for  the  ability  to  generate  Con  A-induced  suppressor  function  when 
pretreated  with  4-HC.  The  results  presented  here  confirm  that  the  T  suppressor 
precursor that is activated by Con A and which is sensitive to very low doses of CYP 
is of the OKT4+,OKT8  -  phenotype. The OKT8  + cells are unable to collaborate in Ig 
secretion before Con A activation, and are active supressors for allogeneic B +  T  cell 
cocultures after Con A activation. Further, OKT8  + cells  have been demonstrated to 
actively suppress  Ig production only in the presence of radiosensitive OKT4  + cells, 
and their suppressor activity is itself radiosensitive (17). In these experiments, however, 
the  OKT8  +  subset  remained  suppressive  after  Con  A  activation,  and  suppressor OZER, COWENS, COLVIN, NUSSBAUM-BLUMENSON, AND SHEEDY  287 
activity was not abolished by pretreatment with 20 nmol/ml 4-HC. In experiments to 
be reported subsequently from this laboratory, OKT8-mediated suppressor function 
as well as cytotoxic activity has been found to be sensitive to 4-HC, although at much 
higher concentrations than differentiated mitogen-induced suppressor or helper activ- 
ity,  suggesting  a  hierarchy  of  human  lymphocyte  functional  sensitivity  to  CYP 
analogous to that described in murine systems (4) with the differentiation of presup- 
pressors being most sensitive, inducer function of intermediate sensitivity, and mature 
suppressor/cytotoxic functions least sensitive. 
The data presented here also demonstrate an interesting and unpredicted effect of 
4-HC pretreatment of the B cell population. Sensitivity of B cell function to CYP was 
among the  earliest  observations of the  immunosuppressive properties  of this  agent 
(18,  20).  Although  B cells do appear to be sensitive to concentrations of 4-HC that 
block Con A-induced suppressor activity, immunoglobulin synthesis in coculture can 
be restored if T  suppressor activity is itself blocked by x-irradiation or 4-HC pretreat- 
ment.  There  are  at  least  two  possible  interpretations  of this  observation.  B  cell 
populations  may themselves consist  of subsets  that  are  differentially susceptible  to 
CYP.  In  this  model,  a  partial  reduction  in  the  total  number of responding  B  cell 
effectors  would  effectively  increase  the  T/B  cell  ratio  and  thus  favor  increased 
suppression  (17)  unless  T  cell  suppressor activity was  blocked.  Alternatively,  all  B 
cells  within  the  treated  population  may  be  modified  in  their  susceptibility  to  T 
suppression  by  CYP-induced  injury,  perhaps  via  alteration  in  B  cell  receptors  as 
suggested by Shand  and  Howard  (1).  Definition of the actual  mechanism involved 
must await more detailed analysis of the effects of 4-HC on B cell membrane integrity 
and intracellular metabolism. 
The precise effects of 4-HC or CYP on T  lymphocyte biology also remain unex- 
plored.  It remains unknown,  for example, whether any of the observed effects of 4- 
HC on T  subset  function differ from those induced  by low doses (<2,000 rad)  of x- 
irradiation.  It is possible, for example, that blockade of suppressor-effector induction 
at  very  low  concentrations  (~10  nmol/ml)  may be  the  result  of extremely subtle 
changes induced  in membrane receptors or protein synthesis because obvious effects 
on blastogenesis are not observed at these concentrations as they are when T  cells are 
treated with 2,000-rad x-irradiation (16). The target T cell of CYP-induced suppressor 
blockade likewise remains undefined. Although these results conclusively demonstrate 
that  low-dose 4-HC blocks the  differentiation  of suppressor precursors  from within 
the  OKT4+,OKT8  -  subset,  4-HC  may  be  acting  directly  on  a  mitogen-induced 
suppressor-precursor cell or on its inducer, both of which apparently share the same 
phenotype  and  are  also  radiosensitive  as  described  by Thomas et  al.  (17,  19,  24). 
These data provide further evidence that the functional heterogeneity and regulation 
of human T  cell populations may be analogous to the T  cell network interactions that 
have  been  well  described  in  murine  systems  (25).  There  is  now  evidence  for  a 
differentiated,  mitogen-independent,  OKT4-,OKT8  +  radiosensitive  suppressor/cy- 
totoxic population that requires an OKT4  + inducer to mediate suppression  (13,  17, 
23), as well as for mitogen-induced OKT4+,OKT8  -  suppressor cells, which retain the 
phenotype of the suppressor-precursor (17).  In addition,  the induction  of suppressor 
function  within  the OKT4+,OKT8  -  subset  is  itself both radiosensitive  (19)  and,  as 
described in this report, sensitive to low doses of 4-HC. By analogy with murine T-T 
cell interactions, the OKT4÷,OKT8  -  target of both x-irradiation and low-dose 4-HC 288  EFFECTS OF CYCLOPHOSPHAMIDE  ON T  SUBSET FUNCTION 
may be the equivalent of the Lyt-123+,Qal  ÷ subset mediating nonimmune feedback 
suppression of Lyt-1 helper cells for antibody responses and which is sensitive to low- 
dose CYP in  vivo  (26).  The  future  application  of 4-HC  as  a  probe  of differential 
lymphocyte subset  sensitivity in  vitro,  in combination with  monoclonal antibodies, 
may be of great benefit in further dissecting T-B and T-T cellular interactions and 
immunoregulation in man. 
Summary 
The  alkylating  agent  cyclophosphamide may  suppress  or  enhance  immune  re- 
sponses  in  vivo but  is  inactive  in  vitro  unless  metabolized  by microsomal enzyme 
activation. 4-hydroperoxycyclophosphamide (4-HC)  is a  synthetic compound that is 
spontaneously converted in aqueous solution to the active metabolites. In this report, 
we examined the in vitro sensitivity of functional human T  cell subsets to 4-HC in a 
polyclonal  B  cell  differentiation  assay  and  in  the  generation  of mitogen-induced 
suppressor cells  for effector B cell  function. Con A-induced T  suppression  of B cell 
differentiation is completely abrogated by a  1-h pretreatment of T  cells  at  very low 
concentrations of between  10  -2 and 20 nmol/ml, whereas inducer T  cell  function is 
sensitive only to concentrations in >40 nmol/ml. The effects of 4-HC on suppressor 
T  cells  appear to occur at concentrations that do not result  in DNA cross-linking or 
decreased blastogenesis. Con A-induced T  suppressors are generated from within the 
OKT4÷,OKT8  -  subset  and  are  sensitive  to  low-dose 4-HC only before activation, 
whereas differentiated  suppressor cells  are resistant  to concentrations in >80 nmol/ 
ml.  Low-dose 4-HC pretreatment  of the  B  cell  population  results  in  abrogation of 
immunoglobulin secretion when treated B cells are cocultured with unfractionated T 
cells,  however, this effect is completely reversible if pretreated B cells  are cocultured 
with  T  cells  devoid  of suppressor  activity.  These  results  demonstrate  that  human 
presuppressor cells for B-effector function differentiate in response to Con A from the 
OKT4+,OKT8  -  subset  and  are  exquisitely  sensitive  to  low concentrations of CYP 
whereas mature suppressor and  inducer functions are resistant  to all  but  very high 
concentrations in vitro. The differential sensitivity of functional T  and B cell  subsets 
to 4-HC in vitro can be a  very useful probe in dissecting immunoregulatory interac- 
tions in man. 
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